Search

Your search keyword '"Lindblom, A. (Annika)"' showing total 65 results

Search Constraints

Start Over You searched for: Author "Lindblom, A. (Annika)" Remove constraint Author: "Lindblom, A. (Annika)"
65 results on '"Lindblom, A. (Annika)"'

Search Results

1. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

2. Gene-environment interactions relevant to estrogen and risk of breast cancer:can gene-environment interactions be detected only among candidate SNPs from genome-wide association studies?

3. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

4. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

5. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

6. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

7. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

8. Genome-wide association study of germline variants and breast cancer-specific mortality

9. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

10. Shared heritability and functional enrichment across six solid cancers

11. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

12. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

13. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

14. Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation

15. Body mass index and breast cancer survival:a Mendelian randomization analysis

16. Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

17. Body mass index and breast cancer survival

18. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

19. Reproductive profiles and risk of breast cancer subtypes

20. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

21. PHIP:a novel candidate breast cancer susceptibility locus on 6q14.1

22. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

23. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

24. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers

25. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

26. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

27. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

28. Genetic predisposition to ductal carcinoma in situ of the breast

29. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

30. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

31. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

32. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

33. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

34. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

35. Prediction of breast cancer risk based on profiling with common genetic variants

36. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

37. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

38. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

39. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

40. Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk

41. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

42. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

43. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

44. MicroRNA related polymorphisms and breast cancer risk

45. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

46. Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

47. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

48. 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

49. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

50. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

Catalog

Books, media, physical & digital resources